VACTERL association is defined by the occurrence of congenital malformations: vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula with esophageal atresia, radial and renal dysplasia, and limb defects. No genetic alterations have been discovered except for some sporadic chromosomal rearrangements and gene mutations. We report a boy with VACTERL association and shawl scrotum with bifid scrotum who presented with a de novo Yq11.223q11.23 microdeletion identified by array CGH. The deletion spans 3.1 Mb and encompasses several genes in the AZFc region, frequently deleted in infertile men with severe oligozoospermia or azoospermia. Herein, we discuss the possible explanation for this unusual genotype-phenotype correlation. We suggest that the deletion of the BPY2 (previously VCY2) gene, located in the AZFc region and involved in spermatogenesis, contributed to the genesis of the phenotype. In fact, BPY2 interacts with a ubiquitin-protein ligase, involved in the SHH pathway which is known to be implicated in the genesis of VACTERL association.

Keywords:
VACTERL, BPY2, Shawl scrotum with bifid scrotum, Sonic hedgehog pathway, Ubiquitin-protein ligase E3A
1.
Aguinaga M, Zenteno JC, Pérez-Cano H, Morán V: Sonic hedgehog mutation analysis in patients with VACTERL association. Am J Med Genet A 152A:781-783 (2010).
2.
Arsić D, Qi B, Beasley S: Hedgehog in the human: a possible explanation for the VATER association. J Paediatr Child Health 38:117-121 (2002).
3.
Arsić D, Beasley SW, Sullivan MJ: Switched-on Sonic hedgehog: a gene whose activity extends beyond fetal development - to oncogenesis. J Paediatr Child Health 43:421-423 (2007).
4.
Aynaci FM, Celep F, Karagüzel A, Baki A, Yildiran A: A case of VATER association associated with 9qh+. Genet Couns 7:321-322 (1996).
5.
Bartsch O, Kuhnle U, Wu LL, Schwinger E, Hinkel GK: Evidence for a critical region for penoscrotal inversion, hypospadias, and imperforate anus within chromosomal region 13q32.2q34. Am J Med Genet 65:218-221 (1996).
6.
Boduroglu K, Alikaşifoglu M, Tunçbilek E, Uludogan S: Ring chromosome 13 in an infant with multiple congenital anomalies and penoscrotal transposition. Clin Dysmorphol 7:299-301 (1998).
7.
Botto LD, Khoury MJ, Mastroiacovo P, Castilla EE, Moore CA, et al: The spectrum of congenital anomalies of the VATER association: an international study. Am J Med Genet 71:8-15 (1997).
8.
Cinti R, Priolo M, Lerone M, Gimelli G, Seri M, et al: Molecular characterisation of a supernumerary ring chromosome in a patient with VATER association. J Med Genet 38:E6 (2001).
9.
Damian MS, Seibel P, Schachenmayr W, Reichmann H, Dorndorf W: VACTERL with the mitochondrial np 3243 point mutation. Am J Med Genet 62:398-403 (1996).
10.
Fujita Y, Kondo K, Hirano M, Kamei Y, Ohashi Y, et al: Hypospadia and incomplete penoscrotal transposition in a boy with the partial deletion of the long arm of the Y chromosome (in Japanese). Nihon Hinyokika Gakkai Zasshi 74:2154-2158 (1983).
11.
Garcia-Barceló MM, Wong KK, Lui VC, Yuan ZW, So MT, et al: Identification of a HOXD13 mutation in a VACTERL patient. Am J Med Genet A 146A:3181-3185 (2008).
12.
Gershoni-Baruch R, Zekaria D: Deletion (13)(q22) with multiple congenital anomalies, hydranencephaly and penoscrotal transposition. Clin Dysmorphol 5:289-294 (1996).
13.
Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, et al: The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140:704-716 (2010).
14.
ISCN 2009: An International System for Human Cytogenetic Nomenclature, Shaffer LG, Slovak ML, Campbell LJ (eds) (S. Karger, Basel 2009).
15.
Kim J, Kim P, Hui CC: The VACTERL association: lessons from the Sonic hedgehog pathway. Clin Genet 59:306-315 (2001).
16.
Kirchhoff M, Bisgaard AM, Stoeva R, Dimitrov B, Gillessen-Kaesbach G, et al: Phenotype and 244k array-CGH characterization of chromosome 13q deletions: an update of the phenotypic map of 13q21.1-qter. Am J Med Genet A 149A:894-905 (2009).
17.
MacKenzie J, Chitayat D, McLorie G, Balfe JW, Pandit PB, Blecher SR: Penoscrotal transposition: a case report and review. Am J Med Genet 49:103-107 (1994).
18.
Martínez-Frías ML, Frías JL, Opitz JM: Errors of morphogenesis and developmental field theory. Am J Med Genet 76:291-296 (1998).
19.
McNeal RM, Skoglund RR, Francke U: Congenital anomalies including the VATER association in a patient with del(6)q deletion. J Pediatr 91:957-960 (1977).
20.
Parida SK, Hall BD, Barton L, Fujimoto A: Penoscrotal transposition and associated anomalies: report of five new cases and review of the literature. Am J Med Genet 59:68-75 (1995).
21.
Pinke LA, Rathbun SR, Husmann DA, Kramer SA: Penoscrotal transposition: review of 53 patients. J Urol 166:1865-1868 (2001).
22.
Reardon W, Zhou XP, Eng C: A novel germline mutation of the PTEN gene in a patient with macrocephaly, ventricular dilatation, and features of VATER association. J Med Genet 38:820-823 (2001).
23.
Repping S, van Daalen SK, Korver CM, Brown LG, Marszalek JD, et al: A family of human Y chromosomes has dispersed throughout northern Eurasia despite a 1.8-Mb deletion in the azoospermia factor c region. Genomics 83:1046-1052 (2004).
24.
Robbins DJ, Fei DL, Riobo NA: The Hedgehog signal transduction network. Sci Signal 5:re6 (2012).
25.
Roessler E, Belloni E, Gaudenz K, Jay P, Berta P, et al: Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 14:357-360 (1996).
26.
Solomon BD: VACTERL/VATER Association. Orphanet J Rare Dis 6:56 (2011).
27.
Solomon BD: The etiology of VACTERL association: current knowledge and hypotheses. Am J Med Genet C Semin Med Genet 178:440-446 (2018).
28.
Solomon BD, Pineda-Alvarez DE, Raam MS, Bous SM, Keaton AA, et al: Analysis of component findings in 79 patients diagnosed with VACTERL association. Am J Med Genet A 152A:2236-2244 (2010).
29.
Stuppia L, Mastroprimiano G, Calabrese G, Peila R, Tenaglia R, Palka G: Microdeletions in interval 6 of the Y chromosome detected by STS-PCR in 6 of 33 patients with idiopathic oligo- or azoospermia. Cytogenet Cell Genet 72:155-158 (1996a).
30.
Stuppia L, Calabrese G, Guanciali Franchi P, Mingarelli R, Gatta V, et al: Widening of a Y-chromosomeinterval-6 deletion transmitted from a father to his infertile son accounts for an oligozoospermia critical region distal to the RBM1 and DAZ genes. Am J Hum Genet 59:1393-1395 (1996b).
31.
Stuppia L, Gatta V, Mastroprimiano G, Pompetti F, Calabrese G, et al: Clustering of Y chromosome deletions in subinterval E ofinterval6 supports the existence of an oligozoospermia critical region outside the DAZ gene. J Med Genet 34:881-883 (1997).
32.
Stuppia L, Gatta V, Fogh I, Gaspari AR, Morizio E, et al: Genomic organization, physical mapping, and involvement in Yq microdeletions of the VCY2 (BPY2) gene. Genomics 72:153-157 (2001).
33.
Tiepolo L, Zuffardi O: Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet 34:119-124 (1976).
34.
Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, et al: Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet 5:933-943 (1996).
35.
Walczak-Sztulpa J, Wisniewska M, Latos-Bielenska A, Linné M, Kelbova C, et al: Chromosome deletions in 13q33-34: report of four patients and review of the literature. Am J Med Genet A 146:337-342 (2008).
36.
Walsh LE, Vance GH, Weaver DD: Distal 13q deletion syndrome and the VACTERL association: case report, literature review, and possible implications. Am J Med Genet 98:137-144 (2001).
37.
Wessels MW, Kuchinka B, Heydanus R, Smit BJ, Dooijes D, de Krijger RR: Polyalanine expansion in the ZIC3 gene leading to X-linked heterotaxy with VACTERL association: a new polyalanine disorder? J Med Genet 47:351-355 (2010).
38.
Wong EY, Tse JY, Yao KM, Tam PC, Yeung WS: VCY2 protein interacts with the HECT domain of ubiquitin-protein ligase E3A. Biochem Biophys Res Commun 296:1104-1111 (2002).
39.
Zhang R, Marsch F, Kause F, Degenhardt F, Schmiedeke E, et al: Array-based molecular karyotyping in 115 VATER/VACTERL and VATER/VACTERL-like patients identifies disease-causing copy number variations. Birth Defects Res 109:1063-1069 (2017).
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.